Success Metrics

Clinical Success Rate

92.3%

Based on 12 completed trials

Completion Rate

92%(12/13)

Active Trials

9(32%)

Results Posted

17%(2 trials)

Terminated

1(4%)

Phase Distribution

Ph phase_4

Ph not_applicable

89%

Ph phase_2

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution28 total trials

Phase 2Efficacy & side effects

1(3.6%)

Phase 4Post-market surveillance

2(7.1%)

N/ANon-phased studies

25(89.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(11)

Completed(12)

Terminated(1)

Other(4)

Detailed Status

Completed12

Recruiting8

unknown3

Not yet recruiting1

Active, not recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

92.3%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (3.6%)

Phase 42 (7.1%)

N/A25 (89.3%)

Trials by Status

not_yet_recruiting14%

active_not_recruiting14%

terminated14%

suspended14%

enrolling_by_invitation14%

completed1243%

recruiting829%

unknown311%

Recent Activity

9 active trials

Showing 5 of 28

enrolling_by_invitationnot_applicable

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more

NCT06526078Not Applicable

Cognitive Training as an Adjunct to Ketamine in Real-world Clinics

Enrolling By Invitation

NCT06770998Not Applicable

A Study of a Novel EEG Neurofeedback System for PTSD Treatment

Recruiting

NCT04578938Phase 4

Ketamine + Cognitive Training for Suicidality in the Medical Setting

Active Not Recruiting

NCT07413718Not Applicable

Inspiratory Muscle Training in Amiotrophyc Lateral Sclerosis

Recruiting

NCT07094906Not Applicable

Handgrip Exercise Training and CKD

Recruiting

NCT04580043Not Applicable

Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors

Completed

NCT06208787Not Applicable

Neurofeedback-Assisted Mindfulness Techniques to Reduce Symptoms of Mental Distress

Completed

NCT05719909Not Applicable

Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment

Suspended

NCT05372029Not Applicable

AAT for Alcohol Use Disorder in Veterans

Recruiting

NCT06121206Not Applicable

Effects of Altitude-like Cognition Training on Neuroplasticity and Cognitive Functions

Completed

NCT06400121Phase 2

Apimostinel + Automated Neurocognitive Training for Depression

Recruiting

NCT06629064Not Applicable

Cognitive Control Training for Extinction in PTSD

Recruiting

NCT06936670Not Applicable

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

Recruiting

NCT04911491Not Applicable

Inspiratory Muscle Strength Training in Chronic Kidney Disease

Recruiting

NCT06752993Not Applicable

Effects of Expiratory Muscle Strength Training in Adolescent Idiopathic Scoliosis

Not Yet Recruiting

NCT04154150Phase 4

Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot

Terminated

NCT02600832Not Applicable

AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study

Completed

NCT04436926Not Applicable

Opioid Approach Bias Modification

Completed

NCT03325777Not Applicable

Approach Bias Retraining to Augment Smoking Cessation

Completed

NCT04430543Not Applicable

Neural and Behavioral Effects of Cognitive Bias Modification (CBM)

Completed

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 28